- Home
- PWM vs PHIO Comparison
PWM vs PHIO Comparison
Compare PWM & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PWM
- PHIO
- Stock Information
- Founded
- PWM 2018
- PHIO 2011
- Country
- PWM Hong Kong
- PHIO United States
- Employees
- PWM N/A
- PHIO N/A
- Industry
- PWM
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- PWM
- PHIO Health Care
- Exchange
- PWM Nasdaq
- PHIO Nasdaq
- Market Cap
- PWM 12.4M
- PHIO 11.2M
- IPO Year
- PWM 2023
- PHIO N/A
- Fundamental
- Price
- PWM $0.37
- PHIO $2.13
- Analyst Decision
- PWM
- PHIO Strong Buy
- Analyst Count
- PWM 0
- PHIO 2
- Target Price
- PWM N/A
- PHIO $9.00
- AVG Volume (30 Days)
- PWM 90.3K
- PHIO 2.7M
- Earning Date
- PWM 08-19-2025
- PHIO 08-18-2025
- Dividend Yield
- PWM N/A
- PHIO N/A
- EPS Growth
- PWM N/A
- PHIO N/A
- EPS
- PWM N/A
- PHIO N/A
- Revenue
- PWM $639,912.00
- PHIO N/A
- Revenue This Year
- PWM N/A
- PHIO N/A
- Revenue Next Year
- PWM N/A
- PHIO N/A
- P/E Ratio
- PWM N/A
- PHIO N/A
- Revenue Growth
- PWM 83.60
- PHIO N/A
- 52 Week Low
- PWM $0.31
- PHIO $0.97
- 52 Week High
- PWM $2.70
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- PWM 41.59
- PHIO 37.22
- Support Level
- PWM $0.37
- PHIO $2.19
- Resistance Level
- PWM $0.40
- PHIO $2.47
- Average True Range (ATR)
- PWM 0.03
- PHIO 0.21
- MACD
- PWM -0.01
- PHIO -0.04
- Stochastic Oscillator
- PWM 7.53
- PHIO 2.88
About PWM Prestige Wealth Inc.
Prestige Wealth Inc is engaged in providing private wealth management services and asset management to high-net-worth and ultra-high-net-worth individuals and enterprises through its subsidiaries.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.